Duration of stay in the intensive care unit (ICU) was similar (HR 1.00, P=0.94) whether insulin was initiated only for blood glucose above 215 mg/dL (liberal control) or was given to maintain levels ...

Intensive glucose control doesn't reduce mortality risk in critically ill patients when compared with conventional glucose control. Instead, it increases the risk for severe hypoglycemia by threefold, ...

Maintaining critically ill patients’ glucose levels once they have left the intensive care unit through hospital discharge, may help bolster better outcomes, according to a study published in Mayo ...

Hyperglycemia is common and associated with poor outcomes in critically ill patients in the intensive care unit. Randomized trials of tight glucose control have shown variable results. New research ...

Please provide your email address to receive an email when new articles are posted on . Adults with diabetes admitted to two ICUs in China were less likely to survive if they had a larger gap between ...

Patients randomized to an intensive control target of 90-130 mg/dL ended up with a similar mean glucose compared with those assigned a standard 140-180 mg/dL treatment target (170 vs 175 mg/dL, P=0.25 ...

In this randomized, controlled trial involving critically ill patients not receiving early parenteral nutrition, tight glucose control did not affect the length of time that ICU care was needed or ...

A new report has found continuous glucose monitoring (CGM) may help reduce staff burden in the intensive care unit (ICU) by reducing the need for blood gas monitoring. Continuous glucose monitoring ...

The belief that the lower the glucose level the better in patients with type 2 diabetes who are at a high risk for MI or stroke has been called into question by an ongoing NIH-supported trial.

The widespread practice of aggressively controlling blood sugar levels in intensive care unit patients may be helping kill some patients, researchers reported on Tuesday. Medicating patients to bring ...

SONDERBORG, Denmark--(BUSINESS WIRE)--Flowsion, the Denmark-based developer of automated continuous blood glucose control systems for intensive care medicine, today announced the CE (Conformité ...